The Trendlines Group Ltd.’s portfolio company, Arcuro Medical Ltd., has ushered in a significant leadership change with the appointment of Jamal Rushdy as the new Chief Executive Officer. Bringing over two decades of industry experience, Rushdy’s tenure as CEO is expected to leverage his vast expertise and standing in the MedTech sector to guide Arcuro Medical through its next phase of development and growth. This strategic move reflects the commitment of Trendlines Group, a prominent player in the private equity scene, to ensure that its investments are led by seasoned professionals capable of achieving competitive market standing and value generation. Arcuro Medical, known for its innovations in the orthopedic space, will benefit from Rushdy’s long-established track record in driving successful operations, expanding market reach, and delivering on product innovation and commercialization.

Private Equity, Healthcare & MedTech,Global

Arcuro Medical Appoints Jamal Rushdy as CEO